ERBB2 and breast cancer: BC cells’ human epidermal growth factor receptor 2 (HER2) and protein kinase B (Akt) were remarkably inactivated when genistein and ADR were combined, suggesting that genistein promotes necrotic-like cell death in BC cells [143].